Cardiovascular profile of loratadine.

Cardiovascular profile of loratadine.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (1999-08-12)

J A Hey, M Affrime, B Cobert, W Kreutner, F M Cuss

摘要

The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine in patients with pre-existing cardiovascular disorders, and the impressive lack of cardiovascular effects at extremely high concentrations in clinical and preclinical studies demonstrate the very safe cardiovascular profile of loratadine.

材料

货号

品牌

产品描述

PHR1376

Supelco

氯雷他定, Pharmaceutical Secondary Standard; Certified Reference Material

L9664

Sigma-Aldrich

氯雷他定, ≥98% (HPLC), powder

1370270

USP

氯雷他定, United States Pharmacopeia (USP) Reference Standard

Y0000603

氯雷他定, European Pharmacopoeia (EP) Reference Standard

Y0000688

氯雷他定, European Pharmacopoeia (EP) Reference Standard